Poteet Stephen J, Holzman Michael D, Melvin Willie V, Sharp Kenneth W, Poulose Benjamin K
Department of Surgical Sciences, Vanderbilt University Medical Center , Nashville, TN 37232, USA.
J Laparoendosc Adv Surg Tech A. 2010 Sep;20(7):587-90. doi: 10.1089/lap.2010.0207.
Percutaneous endoscopic gastrostomy (PEG) and percutaneous endoscopic gastrojejunostomy (PEGJ) are endoscopic procedures often performed by surgeons. No recent population-based study has compared inpatient mortality or length of stay between patients who undergo PEG or PEGJ placement during their hospitalization.
Patients undergoing inpatient PEG or PEGJ placement and who were at least 18 years old were identified from the 2006 Nationwide Inpatient Sample (NIS) database. Baseline characteristics of each group were compared, and outcomes of risk-adjusted inpatient mortality and length of stay were determined. Means were compared from using a complex sample t-test, and proportions were compared from using a complex sample chi-square test, with an alpha level of 0.05 for significance. Bivariate logistic regression was used to evaluate PEG or PEGJ placement as a risk factor for mortality.
In the 2006 NIS, 187,597 discharges were identified, during which a PEG or PEGJ was placed. Ninety-six percent (179,587) of patients underwent PEG placement, and 4% (8010) had PEGJ tubes placed. Fifty-one percent were men, with the mean age for PEG and PEGJ placement of 71.3 +/- 0.3 (mean +/- standard error) and 64.8 +/- 0.8 years (P < 0.05). In the PEG group, 86% of admissions were nonelective, compared to 79% in the PEGJ group (P < 0.05). The primary discharge diagnoses for both groups of patients included acute cerebrovascular disease, aspiration pneumonitis, septicemia, respiratory failure, and intracranial injury. PEG patients had a higher cumulative incidence of congestive heart failure, chronic lung disease, and diabetes. Crude in-hospital mortality for death was 11% for both PEG and PEGJ patients. No difference in mortality was observed in risk-adjusted analyses accounting for patient severity. Mean length of stay was similar for both groups (PEG 20.9 +/- 0.4 days; PEGJ 22.5 +/- 1.1 days). Neither PEG nor PEGJ was identified as a risk factor for inpatient mortality.
Comparative analyses of patients undergoing PEG versus PEGJ revealed no detectable difference between inpatient mortality and hospital length of stay in this large observational study. Both procedures can be performed safely in high-risk populations, with no increased mortality or length of stay incurred by jejunal feeding access. However, further analysis is required to compare more specific short-term outcomes between these populations as well as their respective cost-effectiveness.
经皮内镜下胃造口术(PEG)和经皮内镜下胃空肠造口术(PEGJ)是外科医生常施行的内镜操作。最近尚无基于人群的研究比较住院期间接受PEG或PEGJ置管患者的住院死亡率或住院时间。
从2006年全国住院患者样本(NIS)数据库中识别出至少18岁且接受住院PEG或PEGJ置管的患者。比较每组患者的基线特征,并确定风险调整后的住院死亡率和住院时间等结局指标。采用复杂样本t检验比较均值,采用复杂样本卡方检验比较比例,显著性水平α设定为0.05。采用二元逻辑回归评估PEG或PEGJ置管作为死亡风险因素的情况。
在2006年NIS中,共识别出187,597例进行了PEG或PEGJ置管的出院病例。96%(179,587例)的患者接受了PEG置管,4%(8010例)的患者置入了PEGJ管。51%为男性,PEG和PEGJ置管患者的平均年龄分别为71.3±0.3岁(均值±标准误)和64.8±0.8岁(P<0.05)。PEG组中86%的入院为非选择性入院,而PEGJ组为79%(P<0.05)。两组患者的主要出院诊断包括急性脑血管疾病、吸入性肺炎、败血症、呼吸衰竭和颅内损伤。PEG患者充血性心力衰竭、慢性肺病和糖尿病的累积发生率更高。PEG和PEGJ患者的粗住院死亡率均为11%。在考虑患者病情严重程度的风险调整分析中,未观察到死亡率的差异。两组的平均住院时间相似(PEG为20.9±0.4天;PEGJ为22.5±1.1天)。PEG和PEGJ均未被确定为住院死亡的风险因素。
在这项大型观察性研究中,对接受PEG与PEGJ的患者进行的比较分析显示,住院死亡率和住院时间方面未发现可检测到的差异。两种操作均可在高危人群中安全进行,空肠营养通路不会增加死亡率或住院时间。然而,需要进一步分析以比较这些人群之间更具体的短期结局及其各自的成本效益。